Stephen H. Shoemaker - 08 Aug 2025 Form 4 Insider Report for 180 Life Sciences Corp. (ATNF)

Role
Director
Signature
/s/ Stephen H. Shoemaker
Issuer symbol
ATNF
Transactions as of
08 Aug 2025
Net transactions value
$0
Form type
4
Filing time
11 Aug 2025, 19:48:09 UTC
Previous filing
07 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Shoemaker Stephen H Director 3000 EL CAMINO REAL, BLDG. 4,, SUITE 200, PALO ALTO /s/ Stephen H. Shoemaker 11 Aug 2025 0002048098

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ATNF Common Stock 132,439 08 Aug 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATNF Non-Qualified Stock Option (right to buy) Award $0 +181,422 $0.000000 181,422 08 Aug 2025 Common Stock 181,422 $3.01 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were granted under the 2025 Second Supplemental Option Plan of the Issuer. The options vested immediately, but are not exercisable until stockholder approval of the 2025 Second Supplemental Option Plan is received. If stockholder approval is not received prior to August 8, 2026, the options will be cancelled.
F2 Issued to the Reporting Person in consideration for services rendered and agreed to be rendered to the Issuer as a director of the Issuer.